The role of chemokines and chemokine receptors in multiple sclerosis

LY Cui, SF Chu, NH Chen - International immunopharmacology, 2020 - Elsevier
Multiple sclerosis (MS) is a chronic inflammatory disease that is characterized by leukocyte
infiltration and subsequent axonal damage, demyelinating inflammation, and formation of …

New Th17-specific therapeutic strategies for HIV remission

D Planas, JP Routy, P Ancuta - Current Opinion in HIV and AIDS, 2019 - journals.lww.com
New Th17-specific therapeutic strategies for HIV remission : Current Opinion in HIV and AIDS
New Th17-specific therapeutic strategies for HIV remission : Current Opinion in HIV and AIDS …

Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity

D Hermans, E Houben, P Baeten, H Slaets… - Acta …, 2022 - Springer
Oncostatin M (OSM) is an IL-6 family member which exerts neuroprotective and
remyelination-promoting effects after damage to the central nervous system (CNS) …

[HTML][HTML] Serological biomarkers in autoimmune GFAP astrocytopathy

CC Fu, L Huang, LF Xu, LH Jiang, HL Li… - Frontiers in …, 2022 - frontiersin.org
Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A) is a newly defined
meningoencephalomyelitis. The pathogenesis of GFAP-A is not well understood. The …

Tetramerization of STAT5 promotes autoimmune-mediated neuroinflammation

KL Monaghan, D Aesoph, AG Ammer… - Proceedings of the …, 2021 - National Acad Sciences
Signal tranducer and activator of transcription 5 (STAT5) plays a critical role in mediating
cellular responses following cytokine stimulation. STAT proteins critically signal via the …

Cytokines and biological markers in autoimmune GFAP astrocytopathy: the potential role for pathogenesis and therapeutic implications

A Kimura, M Takemura, Y Yamamoto, Y Hayashi… - Journal of …, 2019 - Elsevier
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP-A) is a corticosteroid-
responsive meningoencephalomyelitis with a poorly understood pathogenesis. We …

Therapeutic targeting of chemokines and chemokine receptors in multiple sclerosis: opportunities and challenges

T Sadeghian-Rizi, H Khanahmad… - CNS & Neurological …, 2018 - ingentaconnect.com
Background & Objective: Multiple sclerosis is an autoimmune demyelinating disease of the
human central nervous system with still unknown etiology. Infiltration, accumulation and …

Avaliação da relação entre parâmetros clínicos patológicos de pacientes portadoras de câncer de mama frente à concentração de quimiocinas

PHR Silva - 2021 - repositorio.ufu.br
1.1 Câncer de mama O câncer de mama é o câncer mais comum entre as mulheres em todo
o mundo e, apesar dos consideráveis esforços diagnósticos e terapêuticos, ainda …

B Cell Responses in an Animal Model of Neuroinflammation: Implications for Multiple Sclerosis

DSW Lee - 2021 - search.proquest.com
Multiple sclerosis is a complex disease with no definitive cause or cure. Positive clinical
trials such as those with anti-CD20 and negative clinical trials such as those with TACI-Ig–all …